Search Results

Business

c-LEcta Reports Record Year With Significant Growth - Aug 23, 2022

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully continued its dynamic business development in fiscal year 2021.

August 23, 2022

·

6 min read

Deals

c-LEcta Announces That It Has Reached Agreement to Be Acquired by Kerry Group

c-LEcta has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company.

February 15, 2022

·

3 min read

c-LEcta Expands Product Range to Include Additional Enzyme NuCLEANase®

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, is launching a newly developed enzyme product.

November 11, 2021

·

3 min read

c-LEcta Continues Its Growth in 2021 and Sees Itself Excellently Positioned for the Future With the ENESYZ Technology Platform

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, continued its growth in 2021.

December 16, 2021

·

4 min read

Policy

c-LEcta: Drug Master File for the Use of the Enzyme DENARASE® in the Pharmaceutical Industry Accepted by the US FDA

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, has announced the submission of a Master File for its best-selling product DENARASE®.

August 31, 2021

·

3 min read

Policy

c-LEcta: European Dossiers Submitted for Approval of New Enzymes in the Food Industry

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, has submitted dossiers for two newly developed enzymes in the food sector.

May 26, 2021

·

4 min read

Business

c-LEcta exceeds EUR 10 million in revenue with significantly higher EBITDA

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, managed to successfully continue its growth in the fiscal year 2020 despite a challenging year overall.

June 15, 2021

·

5 min read

Employees Walking In And Out Of The Door, Some Were Leaving Their Job And Some Were Being Hired At The Same Time. Full Length, Isolated On Solid Color Background. Vector, Illustration, Flat Design, Character.

Layoffs

Turnstone Biologics to Lay Off 60% of Workforce, Overhaul C-Suite

Turnstone is shifting resources to focus on clinical advancement of its selected tumor-infiltrating lymphocyte therapy as three C-suite members exit their roles.

October 11, 2024

·

2 min read

·

Angela Gabriel

EXCiPACT Certification for c-LEcta’s High Production Standards

Certification is deemed an international seal of approval and guarantees the highest quality standards for pharmaceutical excipients and other critical materials used by the pharmaceutical industry, such as DENARASE, a c-LEcta enzyme product that is used in the production of biopharmaceuticals and vaccines

March 2, 2021

·

5 min read

Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX